Assuntos
Eletrodos Implantados/efeitos adversos , Endocardite Bacteriana/etiologia , Infecções por Bactérias Gram-Negativas/etiologia , Marca-Passo Artificial/efeitos adversos , Stenotrophomonas maltophilia/isolamento & purificação , Infecção da Ferida Cirúrgica/microbiologia , Idoso de 80 Anos ou mais , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Farmacorresistência Bacteriana Múltipla , Endocardite Bacteriana/tratamento farmacológico , Endocardite Bacteriana/microbiologia , Evolução Fatal , Feminino , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/microbiologia , Humanos , Marca-Passo Artificial/microbiologia , Embolia Pulmonar/complicações , Stenotrophomonas maltophilia/efeitos dos fármacos , Fatores de Tempo , Valva Tricúspide/microbiologiaRESUMO
Atrial Fibrillation (AFib) is the most common sustained cardiac arrhythmia and a major contributor to cardiovascular morbidity and mortality in the general population. Morbidity and mortality are essentially related to stroke and heart failure. Despite a long history of medical exploration of AFib, many aspects deserve to be considered including AFib definitions, epidemiologic stakes and economic burden posed by AFib. Such aspects are integral part of the evaluation, and accordingly both clinical and therapeutic AFib patients approach. Through this article these various aspects were raised in order to help the clinician to better understand this arrhythmia which is generally easy to identify but often delicate and complex to treat.
Assuntos
Fibrilação Atrial , Fibrilação Atrial/diagnóstico , Fibrilação Atrial/economia , Fibrilação Atrial/epidemiologia , HumanosRESUMO
The implantable cardioverter-defibrillator became in some years the reference treatment of ventricular arrhythmias in association with heart disease. Recently, this technique showed its efficiency in primary prevention for patients at high risk of sudden death. The follow-up of patients with automatic defibrillator requires a detailed knowledge of both electrophysiology and stimulation. This training is based on a practical and theoretical formation. In France, a specific diploma validation is necessary and centres organisation is required. The purpose of this general review is to supply a set of updated data necessary for the coverage and the follow-up of patients with an implantable cardioverter-defibrillator.